Skip to content

Microneedling With Glycolic Acid or Trichloroacetic Acid for Atrophic Acne Scars

Which Is More Effective: Microneedling With 35% Glycolic Acid Peeling or Microneedling With 15% Trichloroacetic Acid Peeling in the Treatment of Atrophic Acne Scars? A Randomized Controlled Study

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07797517
Enrollment
60
Registered
2026-09-01
Start date
2024-12-01
Completion date
2026-07-01
Last updated
2026-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acne Vulgaris, Atrophic Acne Scars

Keywords

Microneedling, Glycolic Acid, Trichloroacetic Acid, Chemical Peel, Dermapen

Brief summary

Atrophic acne scars are depressed scars that can remain after acne has healed. Microneedling is a procedure that uses very small needles to create controlled micro-injuries in the skin, which may stimulate collagen production and improve scar appearance. Chemical peels, including glycolic acid and trichloroacetic acid, may also improve acne scars. This study compares three approaches for treating atrophic acne scars: microneedling followed by a 35% glycolic acid peel, microneedling followed by a 15% trichloroacetic acid peel, and microneedling alone. Sixty adults with atrophic acne scars are randomly assigned to one of the three groups. Participants receive a series of microneedling treatments at 2-week intervals. The study evaluates changes in scar severity, participant satisfaction, treatment-related pain, recovery time after treatment, and side effects. The findings may help identify whether adding either chemical peel to microneedling provides greater benefit than microneedling alone and whether one combination has a shorter recovery time or fewer side effects.

Detailed description

Atrophic acne scars are a common long-term consequence of acne vulgaris. They may appear as ice-pick, boxcar, or rolling scars and can affect facial appearance and quality of life. Available treatments include microneedling, chemical peeling, laser procedures, dermabrasion, subcision, and other scar-directed interventions. The choice of treatment may depend on scar morphology, skin type, recovery time, cost, and risk of adverse effects. Microneedling creates controlled microchannels in the skin and may promote dermal remodeling through wound-healing mechanisms, including fibroblast activation and new collagen formation. Glycolic acid is a superficial chemical peeling agent that promotes epidermal exfoliation and remodeling. Trichloroacetic acid produces controlled protein coagulation and a wound-healing response. Combining microneedling with chemical peeling may provide complementary effects on atrophic acne scars. This single-center randomized controlled study was conducted in the Dermatology and Venereology Department at Kafrelsheikh University Hospitals. A total of 60 adults with atrophic acne scars were allocated equally to one of three groups: microneedling followed by 35% glycolic acid peeling, microneedling followed by 15% trichloroacetic acid peeling, or microneedling alone. Microneedling was performed with a Dermapen device after topical anesthetic application and skin cleansing. In the glycolic acid group, a 35% glycolic acid peel was applied immediately after microneedling and neutralized according to the clinical endpoint and participant tolerance. In the trichloroacetic acid group, a 15% trichloroacetic acid peel was applied immediately after microneedling until an appropriate frosting endpoint was observed. The microneedling-alone group received no chemical peel. Participants received post-procedure instructions that included sun avoidance, sunscreen use, moisturizer as needed, and topical antibiotic use for 3 days. Standardized facial photographs were obtained before and after treatment and during follow-up. Two dermatologists who were blinded to treatment allocation assessed clinical response by comparing standardized photographs. The study also collected participant-reported satisfaction, procedure-related pain, post-procedure downtime, and treatment-related adverse effects, including prolonged erythema and post-inflammatory hyperpigmentation. The study evaluates whether microneedling combined with either 35% glycolic acid or 15% trichloroacetic acid can improve atrophic acne-scar severity more than microneedling alone. It also compares the two combination approaches with respect to treatment tolerance, recovery time, participant satisfaction, and safety.

Interventions

Microneedling of facial atrophic acne scars was performed using a Dermapen device after topical anesthetic application and skin cleansing. The needle penetration depth was 1.5 mm. Microneedling was performed at 2-week intervals according to the study treatment schedule.

PROCEDUREMicroneedling with Glycolic Acid 35% Peel

A 35% glycolic acid peel was applied immediately after microneedling to the acne-scar areas using a cotton-tipped applicator. The peel was neutralized after approximately 3 to 5 minutes, or earlier if frosting, burning, or irritation occurred.

PROCEDUREMicroneedling with Trichloroacetic Acid 15% Peel

A 15% trichloroacetic acid peel was applied immediately after microneedling to the acne-scar areas using a cotton-tipped applicator until an even white frosting endpoint was observed. Post-peel care included washing the skin with sterile saline.

Sponsors

Kafrelsheikh University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

Two dermatologists who assessed standardized pre-treatment and post-treatment facial photographs were blinded to treatment allocation. Participants and treatment providers were not blinded because the post-microneedling procedures differed between study groups.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adults of either sex aged 18 years or older. * Presence of atrophic acne scars of any type or duration. * Fitzpatrick skin type I to IV.

Exclusion criteria

* Active inflammatory acne lesions, skin infection, or a tendency to develop keloids. * Immunocompromised state, facial cancer, or severely damaged facial skin. * Known hypersensitivity to glycolic acid or trichloroacetic acid. * Oral isotretinoin use within 6 months before enrollment. * Pregnancy or breastfeeding. * Inability or unwillingness to adhere to study procedures. * Unrealistic expectations regarding treatment outcomes.

Design outcomes

Primary

MeasureTime frameDescription
Clinical Improvement in Atrophic Acne Scar Severity Using the Goodman and Baron Qualitative Global Acne Scar Grading SystemBaseline to 1 month after the last treatment sessionClinical response is assessed by comparing standardized facial photographs obtained at baseline and 1 month after the last treatment session. Two dermatologists blinded to treatment allocation evaluate scar severity using the Goodman and Baron qualitative global acne scar grading system. Excellent response is defined as a reduction of two scar grades, good response as a reduction of one scar grade, and poor response as no reduction in scar grade.

Secondary

MeasureTime frameDescription
Participant Satisfaction With Treatment1 month after the last treatment sessionParticipant satisfaction is assessed 1 month after the last treatment session and categorized as not satisfied, satisfied, or markedly satisfied.
Treatment-Related Adverse EffectsAt each treatment session through 1 month after the last treatment sessionTreatment-related adverse effects are assessed at each treatment session and follow-up. Recorded adverse effects include prolonged erythema or irritation, post-inflammatory hyperpigmentation or hypopigmentation, herpes simplex flare-up, scarring, and keloid formation.
Procedure-Related Pain SeverityImmediately after each treatment session within up to 30 minutesParticipants rate pain experienced after each treatment session. Pain severity is categorized as mild, moderate, or severe.
Post-Procedure DowntimeAfter each treatment session up to 2 weeksPost-procedure downtime is recorded as the number of days required for recovery after each treatment session.

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 2, 2026